CMS and FDA have launched the RAPID pathway to expedite Medicare reimbursement for breakthrough medical devices. This initiative aims to streamline regulatory and reimbursement processes, significantly benefiting tech professionals by accelerating market access for innovative health technologies. Despite this advancement, automatic reimbursement remains unachieved, indicating further policy developments are anticipated.
Read the full article at STAT News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.



